About Us Services Careers FAQ Contact Us 0
Home Biotechnology Bioreactors Market to Grow at a CAGR of 10.4% by 2031
Bioreactors Market

Bioreactors Market Size, Share & Trends Analysis Report By Product Type (Single-Use, Reusable), By Cell Type (Mammalian Cells, Bacterial Cells, Yeast Cells), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Others), By Reactor Volume (5–20L, 20–250L, 250–1500L, Above 1500L), By End-User (Contract Research Organizations, Biopharmaceutical Companies, Research Labs, CMOS) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRBI1173DR
Last Updated : June 23, 2023
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Bioreactors Market Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Single-Use
        1. By Value
      3. Reusable
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Mammalian Cells
        1. By Value
      3. Bacterial Cells
        1. By Value
      4. Yeast Cells
        1. By Value
    4. By Molecule
      1. Introduction
        1. Molecule By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Stem Cells
        1. By Value
      6. Others
        1. By Value
    5. By Reactor Volume
      1. Introduction
        1. Reactor Volume By Value
      2. 5–20L
        1. By Value
      3. 20–250L
        1. By Value
      4. 250–1500L
        1. By Value
      5. Above 1500L
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Contract Research Organizations
        1. By Value
      3. Biopharmaceutical Companies
        1. By Value
      4. Research Labs
        1. By Value
      5. CMOS
        1. By Value
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Single-Use
        1. By Value
      3. Reusable
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Mammalian Cells
        1. By Value
      3. Bacterial Cells
        1. By Value
      4. Yeast Cells
        1. By Value
    4. By Molecule
      1. Introduction
        1. Molecule By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Stem Cells
        1. By Value
      6. Others
        1. By Value
    5. By Reactor Volume
      1. Introduction
        1. Reactor Volume By Value
      2. 5–20L
        1. By Value
      3. 20–250L
        1. By Value
      4. 250–1500L
        1. By Value
      5. Above 1500L
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Contract Research Organizations
        1. By Value
      3. Biopharmaceutical Companies
        1. By Value
      4. Research Labs
        1. By Value
      5. CMOS
        1. By Value
    7. U.S.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Single-Use
          1. By Value
        3. Reusable
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. Mammalian Cells
          1. By Value
        3. Bacterial Cells
          1. By Value
        4. Yeast Cells
          1. By Value
      3. By Molecule
        1. Introduction
          1. Molecule By Value
        2. Monoclonal Antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Recombinant Proteins
          1. By Value
        5. Stem Cells
          1. By Value
        6. Others
          1. By Value
      4. By Reactor Volume
        1. Introduction
          1. Reactor Volume By Value
        2. 5–20L
          1. By Value
        3. 20–250L
          1. By Value
        4. 250–1500L
          1. By Value
        5. Above 1500L
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Contract Research Organizations
          1. By Value
        3. Biopharmaceutical Companies
          1. By Value
        4. Research Labs
          1. By Value
        5. CMOS
          1. By Value
    8. Canada
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Single-Use
        1. By Value
      3. Reusable
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Mammalian Cells
        1. By Value
      3. Bacterial Cells
        1. By Value
      4. Yeast Cells
        1. By Value
    4. By Molecule
      1. Introduction
        1. Molecule By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Stem Cells
        1. By Value
      6. Others
        1. By Value
    5. By Reactor Volume
      1. Introduction
        1. Reactor Volume By Value
      2. 5–20L
        1. By Value
      3. 20–250L
        1. By Value
      4. 250–1500L
        1. By Value
      5. Above 1500L
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Contract Research Organizations
        1. By Value
      3. Biopharmaceutical Companies
        1. By Value
      4. Research Labs
        1. By Value
      5. CMOS
        1. By Value
    7. U.K.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Single-Use
          1. By Value
        3. Reusable
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. Mammalian Cells
          1. By Value
        3. Bacterial Cells
          1. By Value
        4. Yeast Cells
          1. By Value
      3. By Molecule
        1. Introduction
          1. Molecule By Value
        2. Monoclonal Antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Recombinant Proteins
          1. By Value
        5. Stem Cells
          1. By Value
        6. Others
          1. By Value
      4. By Reactor Volume
        1. Introduction
          1. Reactor Volume By Value
        2. 5–20L
          1. By Value
        3. 20–250L
          1. By Value
        4. 250–1500L
          1. By Value
        5. Above 1500L
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Contract Research Organizations
          1. By Value
        3. Biopharmaceutical Companies
          1. By Value
        4. Research Labs
          1. By Value
        5. CMOS
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Single-Use
        1. By Value
      3. Reusable
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Mammalian Cells
        1. By Value
      3. Bacterial Cells
        1. By Value
      4. Yeast Cells
        1. By Value
    4. By Molecule
      1. Introduction
        1. Molecule By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Stem Cells
        1. By Value
      6. Others
        1. By Value
    5. By Reactor Volume
      1. Introduction
        1. Reactor Volume By Value
      2. 5–20L
        1. By Value
      3. 20–250L
        1. By Value
      4. 250–1500L
        1. By Value
      5. Above 1500L
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Contract Research Organizations
        1. By Value
      3. Biopharmaceutical Companies
        1. By Value
      4. Research Labs
        1. By Value
      5. CMOS
        1. By Value
    7. China
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Single-Use
          1. By Value
        3. Reusable
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. Mammalian Cells
          1. By Value
        3. Bacterial Cells
          1. By Value
        4. Yeast Cells
          1. By Value
      3. By Molecule
        1. Introduction
          1. Molecule By Value
        2. Monoclonal Antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Recombinant Proteins
          1. By Value
        5. Stem Cells
          1. By Value
        6. Others
          1. By Value
      4. By Reactor Volume
        1. Introduction
          1. Reactor Volume By Value
        2. 5–20L
          1. By Value
        3. 20–250L
          1. By Value
        4. 250–1500L
          1. By Value
        5. Above 1500L
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Contract Research Organizations
          1. By Value
        3. Biopharmaceutical Companies
          1. By Value
        4. Research Labs
          1. By Value
        5. CMOS
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Single-Use
        1. By Value
      3. Reusable
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Mammalian Cells
        1. By Value
      3. Bacterial Cells
        1. By Value
      4. Yeast Cells
        1. By Value
    4. By Molecule
      1. Introduction
        1. Molecule By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Stem Cells
        1. By Value
      6. Others
        1. By Value
    5. By Reactor Volume
      1. Introduction
        1. Reactor Volume By Value
      2. 5–20L
        1. By Value
      3. 20–250L
        1. By Value
      4. 250–1500L
        1. By Value
      5. Above 1500L
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Contract Research Organizations
        1. By Value
      3. Biopharmaceutical Companies
        1. By Value
      4. Research Labs
        1. By Value
      5. CMOS
        1. By Value
    7. UAE
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Single-Use
          1. By Value
        3. Reusable
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. Mammalian Cells
          1. By Value
        3. Bacterial Cells
          1. By Value
        4. Yeast Cells
          1. By Value
      3. By Molecule
        1. Introduction
          1. Molecule By Value
        2. Monoclonal Antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Recombinant Proteins
          1. By Value
        5. Stem Cells
          1. By Value
        6. Others
          1. By Value
      4. By Reactor Volume
        1. Introduction
          1. Reactor Volume By Value
        2. 5–20L
          1. By Value
        3. 20–250L
          1. By Value
        4. 250–1500L
          1. By Value
        5. Above 1500L
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Contract Research Organizations
          1. By Value
        3. Biopharmaceutical Companies
          1. By Value
        4. Research Labs
          1. By Value
        5. CMOS
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Single-Use
        1. By Value
      3. Reusable
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. Mammalian Cells
        1. By Value
      3. Bacterial Cells
        1. By Value
      4. Yeast Cells
        1. By Value
    4. By Molecule
      1. Introduction
        1. Molecule By Value
      2. Monoclonal Antibodies
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Stem Cells
        1. By Value
      6. Others
        1. By Value
    5. By Reactor Volume
      1. Introduction
        1. Reactor Volume By Value
      2. 5–20L
        1. By Value
      3. 20–250L
        1. By Value
      4. 250–1500L
        1. By Value
      5. Above 1500L
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Contract Research Organizations
        1. By Value
      3. Biopharmaceutical Companies
        1. By Value
      4. Research Labs
        1. By Value
      5. CMOS
        1. By Value
    7. Brazil
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Single-Use
          1. By Value
        3. Reusable
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. Mammalian Cells
          1. By Value
        3. Bacterial Cells
          1. By Value
        4. Yeast Cells
          1. By Value
      3. By Molecule
        1. Introduction
          1. Molecule By Value
        2. Monoclonal Antibodies
          1. By Value
        3. Vaccines
          1. By Value
        4. Recombinant Proteins
          1. By Value
        5. Stem Cells
          1. By Value
        6. Others
          1. By Value
      4. By Reactor Volume
        1. Introduction
          1. Reactor Volume By Value
        2. 5–20L
          1. By Value
        3. 20–250L
          1. By Value
        4. 250–1500L
          1. By Value
        5. Above 1500L
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Contract Research Organizations
          1. By Value
        3. Biopharmaceutical Companies
          1. By Value
        4. Research Labs
          1. By Value
        5. CMOS
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Bioreactors Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Sartorius Stedim Biotech (Germany)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific Inc. (the US)
    3. Merck KGaA (Germany)
    4. GE Healthcare (the US)
    5. Danaher Corporation (the US)
    6. Eppendorf AG (Germany)
    7. PBS Biotech
    8. Cellexus Ltd.
    9. Applikon Biotechnology Inc.
    10. BioTron Inc.
    11. Shanghai Bailun Biotechnology Co. Ltd.
    12. CerCell
    13. Solaris Biotech Solutions
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Membrane Bioreactors Market Size The market size was valued at USD 4.64 Billion in 2024. It is projected to reach from USD 4.99 Billion by 2025 to USD 8.93 Billion by 2033, growing at a CAGR of 7.55% during the forecast
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.